Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management.

Authors :: Newbold KL
Flux G
Wadsley J
Source :: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2017 May; Vol. 29 (5), pp. 307-309. Date of Electronic Publication: 2017 Jan 27.
Publication Year :: 2017
Abstract: The management of early stage differentiated thyroid cancer (DTC) with low risk of recurrence has been the subject of much interest and investigation in the recent years. Locally advanced DTC and patients with a high risk of recurrent disease however needs further investigation. This short review will look at what constitutes high risk thyroid cancer, the definition of radioiodine refractory disease, the current management and areas of debate within this clinical setting.<br /> (Copyright © 2016. Published by Elsevier Ltd.)

Subjects :: Humans
Risk
Thyroid Neoplasms drug therapy
Iodine Radioisotopes therapeutic use
Thyroid Neoplasms radiotherapy

Language :: English
ISSN :: 1433-2981
Volume :: 29
Issue :: 5
Database :: MEDLINE
Journal :: Clinical oncology (Royal College of Radiologists (Great Britain))
Publication Type :: Academic Journal
Accession number :: 28139379
Full Text :: https://doi.org/10.1016/j.clon.2016.12.008

Full Text Access

Tools